SEC Form 4 · accession 0001178913-15-000717
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadav Kidron
Officer — President and CEO · Director · 10% Owner
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2015 | A | 79,848 | $0.00 | A | 953,948 | D |
Table II — derivative securities
No Table II lines on this filing.